These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34274449)

  • 21. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy.
    Zhang X; Shi H; Lin S; Ba M; Cui S
    Oncol Rep; 2015 Sep; 34(3):1557-64. PubMed ID: 26134156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway.
    Li H; Jiang W; Liu XN; Yuan LY; Li TJ; Li S; Xu SS; Zhang WH; Gao HL; Han X; Wang WQ; Wu CT; Yu XJ; Xu HX; Liu L
    Oncogene; 2020 Sep; 39(36):5825-5838. PubMed ID: 32753651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.
    Sun L; Hu L; Cogdell D; Lu L; Gao C; Tian W; Zhang Z; Kang Y; Fleming JB; Zhang W
    Autophagy; 2017 Apr; 13(4):703-714. PubMed ID: 28121485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
    Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
    Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.
    Subramani R; Gonzalez E; Arumugam A; Nandy S; Gonzalez V; Medel J; Camacho F; Ortega A; Bonkoungou S; Narayan M; Dwivedi Ak; Lakshmanaswamy R
    Sci Rep; 2016 Jan; 6():19819. PubMed ID: 26804739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncoding RNAs as key modulators of autophagy in pancreatic cancer (Review).
    Mukherjee M; Pramanick S; Saha B; Chhatriya B; Goswami S
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.
    Görgülü K; Diakopoulos KN; Ai J; Schoeps B; Kabacaoglu D; Karpathaki AF; Ciecielski KJ; Kaya-Aksoy E; Ruess DA; Berninger A; Kowalska M; Stevanovic M; Wörmann SM; Wartmann T; Zhao Y; Halangk W; Voronina S; Tepikin A; Schlitter AM; Steiger K; Artati A; Adamski J; Aichler M; Walch A; Jastroch M; Hartleben G; Mantzoros CS; Weichert W; Schmid RM; Herzig S; Krüger A; Sainz B; Lesina M; Algül H
    Gastroenterology; 2019 Jan; 156(1):203-217.e20. PubMed ID: 30296435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer.
    Zhang X; Wu D; Aldarouish M; Yin X; Li C; Wang C
    Int J Oncol; 2017 Jan; 50(1):232-240. PubMed ID: 27878249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an autophagy-related signature in pancreatic adenocarcinoma.
    Yue P; Zhu C; Gao Y; Li Y; Wang Q; Zhang K; Gao S; Shi Y; Wu Y; Wang B; Xie J; Meng X
    Biomed Pharmacother; 2020 Jun; 126():110080. PubMed ID: 32203889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
    Hu P; Liang Y; Hu Q; Wang H; Cai Z; He J; Cai J; Liu M; Qin Y; Yu X; Jiang C; Zhang B; Wang W
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1075-1084. PubMed ID: 30307473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.
    Yang A; Rajeshkumar NV; Wang X; Yabuuchi S; Alexander BM; Chu GC; Von Hoff DD; Maitra A; Kimmelman AC
    Cancer Discov; 2014 Aug; 4(8):905-13. PubMed ID: 24875860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
    Kuwada K; Kagawa S; Yoshida R; Sakamoto S; Ito A; Watanabe M; Ieda T; Kuroda S; Kikuchi S; Tazawa H; Fujiwara T
    J Exp Clin Cancer Res; 2018 Dec; 37(1):307. PubMed ID: 30537992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
    Ranjan A; German N; Mikelis C; Srivenugopal K; Srivastava SK
    Tumour Biol; 2017 Jun; 39(6):1010428317705517. PubMed ID: 28618969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
    Hu X; Zhang L; Tian J; Ma J
    World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
    BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Of autophagy and in vivo pancreatic carcinogenesis: the p53 status matters!
    Jonckheere N; Vincent A; Van Seuningen I
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):423-5. PubMed ID: 24939064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.